Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Philippe Bonniaud

Philippe Bonniaud publishes mostly in Pulmonary and Respiratory Medicine, Physiology and Immunology, on topics such as Asthma and respiratory diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and IL-33, ST2, and ILC Pathways.

OpenAlex
World rank
#3,798,368
of 7,710,434 ranked researchers
Rank in France
#159,947
of 324,115
Works
18
Citations
318
Citations per work
17.7
h-index
5
i10-index 3Top 85% in Pulmonary and Respiratory Medicine
Philippe Bonniaud

What does Philippe Bonniaud research?

Philippe Bonniaud's work is mostly in Medicine (52%), Immunology and Microbiology (8%), Health Professions (4%).

Health Sciences: 10 works · 56.0% of their workMedicine: 9 works · 52.0% of their workPulmonary and Respiratory Medicine: 6 works · 32.0% of their workPhysiology: 2 works · 10.0% of their workOncology: 1 works · 6.0% of their workNeurology: 1 works · 4.0% of their workHealth Professions: 1 works · 4.0% of their workGeneral Health Professions: 1 works · 4.0% of their workEverything else: 6 works · 36.0% of their workLife Sciences: 1 works · 8.0% of their workImmunology and Microbiology: 1 works · 8.0% of their workImmunology: 1 works · 8.0% of their workTHEIR WORKPhilippe Bonniaud18works
Life Sciences8%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine952.0%
    2. Health Professions14.0%
  2. Everything else636.0%
    1. Immunology and Microbiology18.0%
  1. 1Pulmonary and Respiratory Medicine32% of their works
  2. 2Physiology10% of their works
  3. 3Immunology8% of their works
  4. 4Oncology6% of their works
  5. 5General Health Professions4% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Philippe Bonniaud's research?

The keywords of their largest research topics: Interstitial Lung Disease, Treatment, Treatment Guidelines, Allergic Diseases, Asthma, Clinical Trials, Fibrosis and Idiopathic Pulmonary Fibrosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Interstitial Lung Disease72 topics
  2. Treatment72 topics
  3. Treatment Guidelines62 topics
  4. Allergic Diseases51 topic
  5. Asthma51 topic
  6. Clinical Trials52 topics
  7. Fibrosis51 topic
  8. Idiopathic Pulmonary Fibrosis51 topic
  9. Targeted Therapy52 topics
  10. ALK Inhibitors31 topic
  11. EGFR Mutations31 topic
  12. IL-3331 topic
  13. Innate Lymphoid Cells31 topic
  14. Pulmonary Hypertension31 topic
  15. Right Heart Assessment31 topic
  16. Dermatomyositis21 topic
  17. Genomic Profiles21 topic
  18. Inflammatory Myopathies21 topic
  19. Psychosocial Work Environment21 topic
  20. Small-Cell Lung Cancer21 topic
  21. Work-related Stress21 topic

Where does Philippe Bonniaud work?

Philippe Bonniaud's main affiliation in the publication record is Inserm, France.

How many publications and citations does Philippe Bonniaud have?

OpenAlex counts 18 works and 318 citations for Philippe Bonniaud, an h-index of 5, ranking #3,798,368 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Philippe Bonniaud

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Philippe Bonniaud. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.